Indications for suboptimal low‐dose direct oral anticoagulants for non‐valvular atrial fibrillation patients

Abstract

With good adherence, the clinical course associated with DOACs is comparatively good. In the future, suboptimal low-dose DOAC therapy may serve as an appropriate choice for some patients with a high risk of stroke and bleeding.